PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm delivers IND to US FDA for Pivotal OA Program, page-25

  1. 60 Posts.
    lightbulb Created with Sketch. 10
    Going to be a nervous 30 days awaiting the response of the FDA! Anything but a go-ahead would be catastrophic. I have faith tho! Best of luck to all the long term holders, it's certainly been a ride.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.